Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men

BACKGROUND: Risk stratification in men with suspicion of prostate cancer (PCa) requires reliable diagnostic tests, not only to identify high-grade PCa, also to minimize the overdetection of low-grade PCa, and reduction of “unnecessary” prostate MRIs and biopsies. This study aimed to evaluate the Sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriks, Rianne J., van der Leest, Marloes M. G., Israël, Bas, Hannink, Gerjon, YantiSetiasti, Anglita, Cornel, Erik B., Hulsbergen-van de Kaa, Christina A., Klaver, O. Sjoerd, Sedelaar, J. P. Michiel, Van Criekinge, Wim, de Jong, Hans, Mulders, Peter F. A., Crawford, E. David, Veltman, Jeroen, Schalken, Jack A., Barentsz, Jelle O., van Oort, Inge M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616754/
https://www.ncbi.nlm.nih.gov/pubmed/33941866
http://dx.doi.org/10.1038/s41391-021-00367-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616754/
https://www.ncbi.nlm.nih.gov/pubmed/33941866
http://dx.doi.org/10.1038/s41391-021-00367-8

Ejemplares similares